Press release
Anti Malarial Drugs Market to Reach US$ 1333.16 Mn by 2030 with 4.3% CAGR
The global anti-malarial drugs market is projected to experience significant growth due to advancements in research and rising awareness about malaria prevention. The market was valued at US $ 992.87 Mn. in 2023 and is expected to grow at a CAGR of 4.3% from 2024 to 2030, reaching nearly US $ 1333.16 Mn. by 2030.๐๐๐ญ ๐ ๐๐ฅ๐จ๐ฌ๐๐ซ ๐ฅ๐จ๐จ๐ค ๐๐ญ ๐ญ๐ก๐ ๐ ๐๐ฆ๐-๐๐ก๐๐ง๐ ๐ข๐ง๐ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ฌ๐ฎ๐๐๐๐ฌ๐ฌ :https://www.maximizemarketresearch.com/request-sample/24938/
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐๐ข๐๐ญ๐ง๐๐ฆ
Vietnam's anti-malarial drugs market has shown steady growth due to government initiatives targeting malaria elimination. Collaborative efforts with global organizations such as the ๐๐จ๐ซ๐ฅ๐ ๐๐๐๐ฅ๐ญ๐ก ๐๐ซ๐ ๐๐ง๐ข๐ณ๐๐ญ๐ข๐จ๐ง (๐๐๐) have led to a reduction in malaria cases. Additionally, partnerships between ๐ฅ๐จ๐๐๐ฅ ๐ก๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐ซ๐ฌ and pharmaceutical companies are driving market growth.
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐ก๐๐ข๐ฅ๐๐ง๐
Thailand is focusing on innovative treatment options to combat drug-resistant malaria strains. Recent mergers, such as the collaboration between ๐๐จ๐ฏ๐๐ซ๐ญ๐ข๐ฌ and ๐ฅ๐จ๐๐๐ฅ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐จ๐ซ๐ฌ, are expected to streamline drug availability. Thailand's National Malaria Elimination Strategy 2024-2030 is a key driver for market expansion.
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐๐ฉ๐๐ง
Japan's pharmaceutical sector has been investing in advanced research to develop next-generation anti-malarial drugs. Recent investments by ๐๐๐ค๐๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ๐ฌ into malaria drug trials underline the country's commitment to tackling global health challenges. Strategic collaborations with regional healthcare providers also contribute to market consolidation.
๐๐ง๐ฅ๐จ๐๐ค ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ฒ ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐ฏ๐ข๐ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค @https://www.maximizemarketresearch.com/request-sample/24938/
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฉ๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐ก๐ข๐ง๐
China has made remarkable progress in eliminating malaria, as highlighted by its certification from WHO in 2021. The market is witnessing a pivot toward manufacturing and exporting anti-malarial drugs. Companies like ๐๐ก๐๐ง๐ ๐ก๐๐ข ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ๐ฌ have increased their R&D investments, aiming for innovative treatments that can cater to global markets.
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐จ๐ฎ๐ญ๐ก ๐๐จ๐ซ๐๐
South Korea's market is characterized by technological advancements in drug formulation. Companies like ๐๐๐ฅ๐ฅ๐ญ๐ซ๐ข๐จ๐ง and ๐๐๐ฆ๐ฌ๐ฎ๐ง๐ ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐๐ฌ are focusing on biosimilar development for anti-malarial treatments. Collaborations with African healthcare initiatives have also opened new opportunities for South Korean manufacturers.
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐๐ข๐ง๐ ๐๐ฉ๐จ๐ซ๐
Singapore is emerging as a hub for clinical trials and pharmaceutical innovation. Recent partnerships between ๐๐ฅ๐๐ฑ๐จ๐๐ฆ๐ข๐ญ๐ก๐๐ฅ๐ข๐ง๐ (๐๐๐) and local research centers have enhanced drug development processes. The government's strong focus on healthcare innovation further bolsters the market outlook.
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฉ๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ ๐๐ง๐ข๐ญ๐๐ ๐๐ญ๐๐ญ๐๐ฌ
The US remains one of the leading markets for anti-malarial drugs due to significant investments in R&D and robust healthcare infrastructure. Companies such as ๐๐๐ข๐ณ๐๐ซ and ๐๐๐ซ๐๐ค have made strides in malaria vaccine research, complementing the drug market. Strategic acquisitions, such as GSK's recent partnership with US-based biotech firms, underscore consolidation trends.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐ญ๐ ๐๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ฒ ๐ฏ๐ข๐๐ฐ๐ข๐ง๐ ๐ญ๐ก๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ @https://www.maximizemarketresearch.com/request-sample/24938/
๐๐ง๐ญ๐ข-๐๐๐ฅ๐๐ซ๐ข๐๐ฅ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐ฎ๐ซ๐จ๐ฉ๐
Europe is focusing on sustainable manufacturing practices in the anti-malarial drugs market. Companies like ๐๐๐ง๐จ๐๐ข and ๐๐๐ฒ๐๐ซ have intensified their efforts in producing affordable treatments. The region also benefits from initiatives like the European & Developing Countries Clinical Trials Partnership (EDCTP), fostering cross-border research collaborations.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฒ๐ฉ๐
Quinine
Chloroquine
Amodiaquine
Pyrimethamine
Others
A medication called quinine is used to treat babesiosis and malaria. When artesunate is unavailable, quinine is used to treat malaria because Plasmodium falciparum is resistant to chloroquine. Patients with malaria can have fewer Plasmodium parasites in their blood by taking artemisinin. Artemisinin side effects include liver problems, tremors, nausea, vomiting, and skin rashes.
๐๐ฒ ๐๐๐ฅ๐๐ซ๐ข๐ ๐๐ฒ๐ฉ๐
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
The two most dangerous species of malaria are Plasmodium falciparum and Plasmodium vivax. The most prevalent malaria parasite in South Africa, Plasmodium falciparum, is also the one that kills the most people worldwide. Plasmodium falciparum grows rapidly, resulting in blocked blood arteries and significant blood loss. Asia Pacific is where Plasmodium vivax is primarily found. Each year, Plasmodium vivax causes malaria in 19-50 million people.
๐๐ฒ ๐๐๐๐ก๐๐ง๐ข๐ฌ๐ฆ ๐จ๐ ๐๐๐ญ๐ข๐จ๐ง
Resistance
Prevention
๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ
Hospitals & Retail Pharmacy
E-Commerce
Others
๐๐๐ญ ๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:https://www.maximizemarketresearch.com/market-report/global-anti-malarial-drugs-market/24938/
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
1. Mylan Labs
2. Cipla
3. GlaxoSmithKline
4. Novartis
5. Roche
6. Bayer AG
7. Lincoln Pharmaceuticals
8. Strides Pharma Science
9. Glenmark Pharmaceuticals
10.Alliance Pharmaceuticals
11.F. Hoffmann-La Roche AG
12.Alvizia Healthcare Pvt. Ltd.
13.Ipca Laboratories Ltd.
14.Merck & Co., Inc
15.Sun Pharmaceutical Industries Ltd.
16.Zydus Cadila.
17.Ranbaxy Laboratories
๐๐ก๐๐๐ค ๐จ๐ฎ๐ญ ๐จ๐ฎ๐ซ ๐ญ๐ซ๐๐ง๐๐ข๐ง๐ ๐ฌ๐ญ๐ฎ๐๐ข๐๐ฌ ๐ญ๐จ ๐ฎ๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฌ๐ก๐ข๐๐ญ๐ฌ :
โฆ Thin Boiling Starch Market https://www.maximizemarketresearch.com/market-report/thin-boiling-starch-market/147120/
โฆ Wireless Keyboard Market https://www.maximizemarketresearch.com/market-report/global-wireless-keyboard-market/3701/
โฆ Global Cesium Market https://www.maximizemarketresearch.com/market-report/global-cesium-market/89395/
โฆ Industrial Palletizing Robots Market https://www.maximizemarketresearch.com/market-report/industrial-palletizing-robots-market/77409/
โฆ Operational Technology Market https://www.maximizemarketresearch.com/market-report/operational-technology-market/171620/
โฆ Global Fall Detection System Market https://www.maximizemarketresearch.com/market-report/global-fall-detection-system-market/25573/
โฆ Global Conductive Inks Market https://www.maximizemarketresearch.com/market-report/global-conductive-inks-market/33202/
โฆ Enterprise Risk Management Market https://www.maximizemarketresearch.com/market-report/global-enterprise-risk-management-market/39991/
โฆ Global Soy Milk Market https://www.maximizemarketresearch.com/market-report/global-soy-milk-market/77593/
โฆ Ductless HVAC System Market https://www.maximizemarketresearch.com/market-report/global-ductless-hvac-system-market/28305/
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti Malarial Drugs Market to Reach US$ 1333.16 Mn by 2030 with 4.3% CAGR here
News-ID: 3810518 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

India Food Packaging Market to Reach USD 29.65 Billion by 2032 at 7.8% CAGR Indu โฆ
Rising demand for convenience foods and sustainable packaging solutions is driving the India food packaging market growth.
Opening Paragraph:
According to a recent industry analysis, the India Food Packaging Market was valued at USD 14.89 billion in 2024 and is projected to reach USD 29.65 billion by 2032, growing at a CAGR of 7.8% during the forecast period. This growth is attributed to increasing consumer demand for packaged foods, rising urbanization, andโฆ

Trailers Market Size to Reach USD 60.36 Billion by 2032 at 6% CAGR - Trends, Dri โฆ
Rising freight transportation demand, growing logistics networks, and e-commerce expansion are expected to fuel global trailer market growth through 2032.
Opening Paragraph
According to a new report by Maximize Market Research, the Global Trailers Market was valued at USD 48.10 billion in 2024 and is projected to reach USD 75.36 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period (2025-2032). This growth is drivenโฆ

Protein Bar Market to Reach USD 8.25 Billion by 2032 at 6.5% CAGR
Rising health awareness, fitness culture, and the need for convenient nutrition are driving consistent growth in the global protein bar market.
Opening Paragraph
According to a new report by Maximize Market Research, the global Protein Bar Market was valued at USD 4.98 billion in 2024 and is projected to reach USD 8.25 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period (2025-2032). Growth isโฆ

FPV Drone Market to Soar to USD 562.44M by 2032 at 19.06% CAGR FPV Drone Forecas โฆ
Global FPV Drone Market is projected to grow rapidly through 2032, fueled by immersive technology, drone racing, and commercial applications.
Opening Paragraph:
According to a recent study by Maximize Market Research, the global FPV (First-Person View) Drone Market was valued at USD 139.30 million in 2024 and is forecast to reach USD 562.44 million by 2032, expanding at a compound annual growth rate (CAGR) of 19.06% during 2025-2032. The growth is propelledโฆ
More Releases for Plasmodium
Plasmodium Vivax Malaria Market Outlook 2025-2034, Global Trends and Forecast An โฆ
Plasmodium vivax is one of the most common species of malaria parasites, responsible for a large proportion of malaria cases worldwide. Unlike Plasmodium falciparum, which causes more severe malaria, P. vivax malaria can still lead to significant morbidity and mortality if not properly managed. As global efforts to combat malaria intensify, the Plasmodium vivax malaria market is experiencing notable growth, driven by advancements in treatment options, diagnostics, and vaccine development.โฆ
Highlights On Future Development in Plasmodium Falciparum Diagnostics Market 202 โฆ
The new research study that is being offered here is an excellent compilation of numerous analyses of important elements of the Global Plasmodium Falciparum Diagnostics Market. It clarifies how the Plasmodium Falciparum Diagnostics market is anticipated to expand globally over the course of the projected period 2022-2030. The strengths and weaknesses of the global Plasmodium Falciparum Diagnostics market and the many companies operating therein are thoroughly explained using SWOT analysisโฆ
Malaria Diagnostics Market 2021 Growth, COVID Impact, Trends Analysis Report 202 โฆ
The Malaria Diagnostics Market is expected to register a CAGR of 4% over the forecast period 2021-2027.
Malaria is a parasitic infection and can be very fatal if not treated. The plague is spread by an infected female Anopheles mosquito bite. The bite transfers the Plasmodium parasite to the human body. There are also many types of Plasmodium parasites such as Plasmodium vivax, Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodiumโฆ
NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-py โฆ
The National Center for Genetic Engineering and Biotechnology (BIOTEC) is a research center under the umbrella of the National Science and Technology Development Agency (NSTDA), Ministry of Higher Education, Science, Research and Innovation of Thailand. The center was founded on 20 September 1983 and became a member of NSTDA in 1991.
BIOTECโs Health and Medicine program focuses its research and development to advance knowledge on neglected diseases such as malaria. Malariaโฆ
Anti-Malarial Drug Market Size , share and growth with top key players GlaxoSmit โฆ
The global anti-malarial drugs market is gradually developing due to the surge in prevalence rate of malaria globally. Favorable government regulations, development of multi-drug resistance (MDR), and increase in research, development, and innovation in terms of anti-malaria therapeutics is anticipated to supplement market growth. However, possible side effects of anti-malaria drugs such as anxiety, dizziness insomnia, and others impede the growth of this market.
Anti-malarial drugs are medications used for theโฆ
Outlook on Global Antimalarial Drug Market Size, Status and Forecast 2022 - Baye โฆ
ResearchMoz added Latest Research Report titled " Global Antimalarial Drug Market Size, Status and Forecast 2022 " to it's Large Report database.
This report studies the global Antimalarial Drug market, analyzes and researches the Antimalarial Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Pfizer
GlaxoSmithKline
Ranbaxy Laboratories
Ipca Laboratories Ltd
Zydus Cadila
Merck KGaA
Novartis AG
Alvizia Health Care
Bayer
Roche
Request for Sampleโฆ